Company / Return on Assets (ROA)
Zomedica Corp. Return on Assets (ROA) History
FY2022-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Return on Assets (ROA)
-64.4%
FY2025
5-year range
-64.4% / -6.1%
FY2022-FY2025
Trend
-184.4%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Return on Assets (ROA) has declined for 3 consecutive years, from -6.1% in FY2022 to -64.4% in FY2025.
Based on SEC 10-K filings.
-64.4% in FY2025 with a 3-year CAGR of -58.4%.
Declined from -13.6% to -64.4% over the past 2 years.
Return on Assets (ROA) over time
Growth rates
- 3-Year Change
- -58.4pp
- 5-Year Change
- -
- 10-Year Change
- -
Key checks
Key Insights
- Zomedica Corp.'s return on assets (roa) has declined for 3 consecutive years.
- In FY2025, return on assets (roa) decreased 184.4% year-over-year.
Company context
Key Data Points
- Altman Z-Score 0.66 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Return on Assets (ROA)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | -64.4% | -184.4% |
| FY2024 | -22.7% | -66.1% |
| FY2023 | -13.6% | -124.0% |
| FY2022 | -6.1% | - |
As of FY2025 · SEC 10-K · Updated Jun 29, 2026